Genetically engineered bacterium for producing chrysoidic acid as well as construction method and application of genetically engineered bacterium

By screening the Δ5 desaturase gene and constructing the Yarrowia lipolytica genetically engineered strain, the problem of lack of synthesis of oxalic acid in microorganisms was solved, and efficient production of oxalic acid on a simple culture medium was achieved, simplifying the process flow and reducing costs.

CN119060969APending Publication Date: 2024-12-03ZHEJIANG FORESTRY UNIVERSITY +1
View PDF 0 Cites 2 Cited by

Patent Information

Application Number
CN202310648906.3
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2023-06-02
Publication Date
2024-12-03

AI Technical Summary

Technical Problem

There is currently no method for microorganisms to synthesize oxalic acid, which leads to the complex process and high cost of extracting oxalic acid from gymnosperm Torreya, and lacks biosynthesis solutions.

Method used

Screen and provide the Δ5 desaturase gene (TgDES) from Torreya lipolytica as the chassis cell, integrate expression cassettes through CRISPR/Cas9 technology to construct genetically engineered strains of monosine acid, using simple carbon sources such as glucose and glycerol. Fermentation to synthesize monazole.

Benefits of technology

It realizes the simple, fast and efficient construction of the genetically engineered strain of oxanthic acid, shortens the construction cycle of the engineered bacteria, and can efficiently produce oxanthic acid on a simple culture medium, with good application prospects.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119060969A_ABST
    Figure CN119060969A_ABST
Patent Text Reader

Abstract

The invention provides a genetic engineering bacterium for producing chrysolic acid as well as a construction method and application of the genetic engineering bacterium. The genetic engineering bacterium expresses a gene C16 / 18 fatty acid elongase (ME3S) from Mortierella alpina, a gene delta 9 elongase (EgD9eS) from Euglenagracis, a gene delta 12 desaturase (FmD12S) from Fusarimononoliforme and a gene delta 5 desaturase gene (TgDES) from Torreyagranis. According to the method, the yarrowia lipolytica is taken as a chassis cell, and the golden acid expression module is linearized and then transferred into the yarrowia lipolytica body, so that the method has the advantages of simplicity, rapidness and high efficiency, and the construction period of engineering bacteria is shortened.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the field of genetic engineering, and in particular to a succinic acid-producing genetic engineering bacterium and a construction method and application thereof. Background Art

[0002] Cis-5Z, 11Z, 14Z-eicosatrienoic acid is a fatty acid unique to gymnosperms. It has special biological activity, significantly affects intracellular lipid metabolism, prevents hyperlipidemia, high cholesterol, and atherosclerosis, and has good anti-inflammatory effects. The Δ5 multi-subunit interrupted unsaturated double bond is the main structural feature.

[0003] At present, succinic acid is mainly found in the seed oil of the gymnosperm Torreya grandis (Torreyagrandis), but Torreya grandis is a perennial tree with a long growth cycle and a complex oil and fatty acid extraction process. Relatively speaking, microbial synthesis can solve the shortcomings of extraction from plants, with the advantages of simple production process, low cost and good product quality.

[0004] Safosaic acid is synthesized in vivo by Δ5 desaturase catalysis. However, there is currently no method for synthesizing safosaic acid by microorganisms, so there is an urgent need in the art to screen the corresponding Δ5 desaturase and develop a method for biosynthesizing safosaic acid. Summary of the invention

[0005] The purpose of the present invention is to provide a gene engineering bacterium producing pyralidone and a construction method and application thereof, so as to solve at least one technical problem raised by the background technology. The specific aspects of the present invention include:

[0006] The present invention first provides a Δ5 desaturase derived from Torreya grandis, characterized in that the amino acid sequence of the enzyme is shown in SEQ ID NO:2.

[0007] The second aspect of the present invention provides the above-mentioned Δ5 desaturase gene (TgDES), characterized in that the nucleotide sequence is as shown in SEQ ID NO: 1, or the sequence after codon optimization is as shown in SEQ ID NO: 6.

[0008] The third aspect of the present invention provides a succinic acid-producing genetically engineered bacterium, characterized in that the succinic acid-producing genetically engineered bacterium contains and is capable of expressing genes ME3S, EgD9eS, FmD12S and TgDES, and the nucleotide sequences of the genes ME3S, EgD9eS, FmD12S and TgDES are shown in SEQ ID No: 3, SEQ ID No: 4, SEQ ID No: 5 and SEQ ID No: 6, respectively.

[0009] In a specific embodiment of the present invention, the chassis cell of the succinic acid-producing genetically engineered bacteria is Yarrowia lipolytica, preferably Ku70-knocked-out Yarrowia lipolytica.

[0010] In a specific embodiment of the present invention, the gene fragment is expressed under the control of a strong endogenous promoter and terminator of Yarrowia lipolytica; preferred promoters include pYAT1, pTEFIN, pGPD, pFBA1 and pEXP; preferred terminators include tLIP2 and tPEX20.

[0011] In a specific embodiment of the present invention, EgD9eS is introduced in multiple copies.

[0012] In a specific embodiment of the present invention, the genetically engineered bacteria comprises a ME3S-EgD9eS gene fragment; preferably, the fragment is inserted into the KU80 site.

[0013] In a specific embodiment of the present invention, the genetically engineered bacteria comprises a FmD12S-EgD9eS gene fragment, and preferably, the fragment is inserted into the IntC-2 site.

[0014] In a specific embodiment of the present invention, the TgDES gene fragment is inserted into the IntC-3 site.

[0015] The fourth aspect of the present invention provides a method for constructing the above-mentioned pyralidone-producing genetically engineered bacteria, characterized in that it comprises the following steps:

[0016] An expression cassette containing the gene C16 / 18 fatty acid elongase (ME3S) from Mortierella alpina, the gene Δ9 elongase (EgD9eS) from Euglenagracilis, and the functional elements of the endogenous strong promoter and terminator of Yarrowia lipolytica was constructed; the expression cassette was integrated into the KU80 site on the Yarrowia lipolytica genome to obtain the recombinant Yarrowia lipolytica strain YL-1;

[0017] An expression cassette containing the gene Δ12 desaturase (FmD12S) from Fusarium monoliforme, the gene Δ9 elongase (EgD9eS) from Euglenagracilis, and the functional elements of the endogenous strong promoter and terminator of Yarrowia lipolytica was constructed; the expression cassette was integrated into the IntC-2 site on the genome of strain YL-1 to obtain the recombinant Yarrowia lipolytica strain YL-2;

[0018] An expression cassette containing the Δ5 desaturase gene (TgDES) from Torreyagrandis and the functional elements of the strong endogenous promoter and terminator of Yarrowia lipolytica was constructed; the expression cassette was integrated into the IntC-3 site on the genome of strain YL-2 to obtain the recombinant Yarrowia lipolytica strain YL-3, i.e., the succinic acid-producing genetically engineered strain.

[0019] In a fifth aspect, the present invention provides a method for synthesizing sauroponic acid, using the sauroponic acid-producing genetically engineered bacteria described in the third aspect of the present invention or the Yarrowia lipolytica strain YL-3 constructed by the method described in the fourth aspect of the present invention to ferment and synthesize sauroponic acid.

[0020] Technical effect:

[0021] (1) The present invention uses Yarrowia lipolytica as a chassis cell, linearizes the succinic acid expression module, and then transfers it into the Yarrowia lipolytica, and uses CRISPR / Cas9 technology to mediate integration into the designed chromosome position. It has the advantages of being simple, rapid, and efficient. The integrated engineering strain can be obtained in 2 to 3 weeks, which significantly shortens the construction cycle of the engineering bacteria.

[0022] (2) The present invention can utilize simple culture medium to ferment and produce the unconventional fatty acid succinic acid. The obtained engineered bacteria can utilize simple carbon sources such as glucose and glycerol to ferment and produce succinic acid, and has good application prospects. BRIEF DESCRIPTION OF THE DRAWINGS

[0023] In order to more clearly illustrate the technical solutions of the embodiments of the present invention, the drawings required for use in the embodiments are briefly introduced below. It should be understood that the following drawings only show certain embodiments of the present invention and therefore should not be regarded as limiting the scope. For ordinary technicians in this field, other related drawings can be obtained based on these drawings without creative work.

[0024] Figure 1 Schematic diagram of the plasmid map of the recombinant plasmid p1-ME3S+EgD9eS.

[0025] Figure 2 Schematic diagram of the plasmid map of the recombinant plasmid p2-FmD12S+EgD9eS.

[0026] Figure 3 Schematic diagram of the plasmid map of the recombinant plasmid p3-TgDES.

[0027] Figure 4 This is the GC analysis diagram of the engineering strain YL-3 synthesizing succinic acid.

[0028] Figure 5 This is the GC-MS analysis of the engineered strain YL-3 synthesizing succinic acid.

[0029] Figure 6 Metabolic pathway diagram for the synthesis of succinic acid by the engineered strain. DETAILED DESCRIPTION

[0030] In order to make the purpose, technical scheme and advantages of the embodiments of the present invention clearer, the technical scheme in the embodiments of the present invention will be described clearly and completely below. If the specific conditions are not specified in the embodiments, they are carried out according to conventional conditions or conditions recommended by the manufacturer. If the manufacturer of the reagents or instruments used is not specified, they are all conventional products that can be purchased commercially.

[0031] The features and performance of the present invention are further described in detail below in conjunction with the embodiments.

[0032] In a first aspect, an embodiment of the present invention provides a Δ5 desaturase gene, specifically a Δ5 desaturase gene from Torreya grandis, the nucleotide sequence of which is shown in SEQ ID NO: 1.

[0033] In one embodiment, the amino acid sequence of the protein encoded by the Δ5 desaturase gene is shown in SEQ ID NO:2.

[0034] In the second aspect, an embodiment of the present invention provides a succinic acid-producing genetically engineered bacterium, characterized in that the succinic acid-producing genetically engineered bacterium contains and can express genes ME3S, EgD9eS, FmD12S and TgDES, and the nucleotide sequences of the genes ME3S, EgD9eS, FmD12S and TgDES are shown in SEQ ID No: 3, SEQ ID No: 4, SEQ ID No: 5 and SEQ ID No: 6, respectively.

[0035] In a third aspect, an embodiment of the present invention provides a method for constructing a succinic acid-producing genetically engineered bacterium, comprising the following steps:

[0036] A p1 plasmid vector was constructed, which contained a functional element expression cassette consisting of a gene C16 / 18 fatty acid elongase from Mortierella alpina, a gene Δ9 elongase from Euglen a gracilis, and a strong endogenous promoter and terminator of Yarrowia lipolytica; the expression cassette was transformed and integrated into the KU80 site on the Yarrowia lipolytica genome by the lithium acetate method to obtain a recombinant Yarrowia lipolytica strain YL-1;

[0037] A p2 plasmid vector was constructed, which contained a functional element expression cassette consisting of a gene Δ12 desaturase from Fusarium monoliforme, a gene Δ9 elongase from Euglena gracilis, and a strong endogenous promoter and terminator of Yarrowia lipolytica; the recombinant Yarrowia lipolytica strain YL-2 was obtained by transformation and integration into the IntC-2 site on the genome of strain YL-1 using the lithium acetate method;

[0038] A p3 plasmid vector was constructed, comprising a Δ5 desaturase gene from Torreya grandis and a functional element expression cassette composed of a strong endogenous promoter, terminator and Yarrowia lipolytica. The recombinant Yarrowia lipolytica strain YL-3 was obtained by transformation and integration into the IntC-3 site on the genome of strain YL-2 using the lithium acetate method, and the recombinant Yarrowia lipolytica strain YL-3 was obtained, which was a genetically engineered bacterium producing succinic acid.

[0039] The following is a detailed description of a method for constructing a phosphodiesterase-producing genetically engineered bacterium with reference to specific examples. The materials and reagents used in the following examples, unless otherwise specified, can all be obtained from commercial sources. The culture media used in the examples were prepared according to conventional preparation methods.

[0040] The primers used were synthesized by Beijing Qingke Biotechnology Co., Ltd. The sequences of the primers are shown in the following table:

[0041]

[0042]

[0043]

[0044]

[0045]

[0046]

[0047]

[0048]

[0049]

[0050]

[0051]

[0052]

[0053]

[0054]

[0055]

[0056]

[0057]

[0058]

[0059] Unless otherwise specified, the experimental methods used in the following examples are all conventional methods, usually according to conventional conditions such as those described in Sambrook et al., Molecular Cloning: A Laboratory Manual (New York: Cold Spring Harbor Laboratory Press, 1989), or according to the conditions recommended by the manufacturer.

[0060] The yeast involved in the present invention is Yarrowia lipolytica, which is derived from the W29 strain with Cas9 at the KU70 site donated by Dr. Dai Zongjie of Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences.

[0061] To construct the integrative strain, a single gRNA vector and homologous donor plasmid for gene knock-in were constructed by the CRISPR / Cas9 system. The PgRNA-YL vector was donated by Dr. Zongjie Dai from Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences. The G1-G7 knockout vectors targeting different integration sites (KU80, IntC-2, IntC-3, IntD-4, IntE-1, IntE-3, and IntE-4) were preserved in this laboratory. The G1-G3 vectors were used in the present invention.

[0062] The homologous donor plasmid, i.e., the integration vector, is constructed with pMD-19T as the backbone to form p1-p7 integration vectors with different integration sites (KU80, IntC-2, IntC-3, IntD-4, IntE-1, IntE-3, IntE-4). The promoters of the p1-p7 integration vectors are pYAT1, pTEFIN, pGPD, pFBA1 and pEXP, and the terminators are tLIP2 and tPEX20, which are preserved in this laboratory. The present invention uses the p1-p3 vector.

[0063] The specific biological material information is as follows:

[0064]

[0065] In the embodiment of the present invention, the Δ5 desaturase gene TgDES from Torreya grandis has the function of catalyzing 20:2 Δ11,14Preferably, in order to increase the expression level of the gene TgDES, the codon preference of Yarrowia lipolytica can be optimized, and the nucleotide sequence of the optimized gene TgDES is shown in SEQ ID No: 6 by chemical synthesis (synthesized by Nanjing GenScript Biotechnology Co., Ltd.).

[0066] Construction of p1 integration plasmid vector

[0067] (1) The Yarrowia lipolytica W29 genome was used as a template and the primer pairs pYAT1-F / pYAT1-R and pTEF-F / pTEF-R were used to amplify the Y. lipolytica endogenous strong promoters YAT1 and TEFIN, respectively. Overlap PCR was then used to amplify the fusion bidirectional promoter fragment.

[0068] (2) The p1 vector was linearized using primer pair tPEX20-F / tLIP2-F to obtain the linearized p1 vector backbone.

[0069] (3) The primer pair ME3S-F / ME3S-R was used to amplify the gene ME3S, and the primer pair EgD9eS-F / EgD9eS-R was used to amplify the gene EgD9eS.

[0070] (4) The linearized p1 backbone fragment, bidirectional promoter fragment, ME3S gene fragment, and EgD9eS gene fragment were assembled using the Gibson assembly method to obtain a recombinant vector. ME3S and EgD9eS were expressed under the control of promoters TEFIN and YAT1 and terminators tLIP2 and tPEX20, respectively, and transferred into DH5α competent cells. The positive clones were screened on LB plates containing 100 mg / ml ampicillin using an ampicillin tag. After colony PCR and sequence alignment, the recombinant plasmid vector p1-ME3S-EgD9eS ( Figure 1 ).

[0071] Construction of recombinant Yarrowia lipolytica capable of producing succinic acid:

[0072] (1) Using the p1-ME3S-EgD9eS recombinant plasmid as a template, primers YL-P1-F / YL-P1-R were used to obtain the linearized target gene fragment T1-ME3S-EgD9eS (containing the ME3S gene and the EgD9eS gene). The T1-ME3S-EgD9eS fragment and its corresponding knockout plasmid G1 were transformed into the KU80 site of the original strain W29 using the conventional lithium acetate transformation method.

[0073] (2) Screen positive transformants on YPD plates containing hygromycin B (250 mg / L) or nosericin (400 mg / L). After yeast transformation, spread it on YPD plates and grow in an incubator at 30°C for 1-2 days. Then, pick a single clone and place it in a deep-well plate containing 2.5 mL YPD and culture it at 30°C and 500 rpm for 24 hours. The engineered strain YL-1 was generated.

[0074] (3) YL-1 was re-inoculated onto a new YPD plate containing hygromycin B and cultured for 1 day to obtain more successful gRNA marker deletion. A single colony was picked from the culture dish and inoculated into a 24-well plate containing 2.5 mL of YNB for subsequent strain transformation.

[0075] (4) To improve 20:2 Δ11,14 The yield of Δ12 desaturase gene FmD12S in the upstream of its synthesis pathway was further overexpressed, and the copy number of gene EgD9eS was increased to construct p2-FmD12S-EgD9eS plasmid vector ( Figure 2 ) The process is the same as in Example 1 above. Primers YL-P2-F / YL-P2-R are used to obtain the linearized target gene fragment T2-FmD12S-EgD9eS (genes containing FmD12S and EgD9eS). The T2-FmD12S-EgD9eS fragment and its corresponding knockout plasmid G2 are transformed and integrated into the IntC-2 site on the genome of strain YL-1 by the lithium acetate method to obtain the recombinant Yarrowia lipolytica strain YL-2.

[0076] (5) Construction of p3-TgDES1 plasmid vector ( Figure 3 ) The process was the same as in Example 1 above. Primers YL-P3-F / YL-P3-R were used to obtain the linearized target gene fragment T3-TgDES (including the TgDES gene). The T3-TgDES fragment and its corresponding knockout plasmid G3 were transformed and integrated into the IntC-3 site on the genome of strain YL-2 by the lithium acetate method to obtain the recombinant Yarrowia lipolytica strain YL-3.

[0077] Fermentation of genetically engineered bacteria and detection of succinic acid:

[0078] The method for synthesizing sauroponic acid by shake flask fermentation of any recombinant Yarrowia lipolytica strain YL-3, preferably, the recombinant strain YL-3 can detect sauroponic acid.

[0079] (1) 48 h after seed activation of recombinant strain YL-3 in YPD medium;

[0080] (2) Inoculate the culture medium at a ratio of 1:60 into a sterilized shake flask containing 30 mL of YPD medium;

[0081] (3) After 5 days of shaking flask fermentation at 20°C and 220 rpm, the cells were collected and freeze-dried;

[0082] (4) Grind the freeze-dried powder and add 6 mL of chloroform:methanol (2:1) solution, and shake and extract for 16 h;

[0083] (5) After centrifugation at 4000 rpm for 10 min, take the supernatant into another centrifuge tube;

[0084] (6) After adding 2 mL of methanol and 3 mL of 0.9% NaCl solution, centrifuge at 3000 rpm for 10 min, pipette the lower chloroform layer into a clean glass tube, and blow dry under a nitrogen blower;

[0085] (7) Add 2.6 mL of methanol-sulfuric acid solution (98:2) into the glass tube and react at 85 °C for 3 h;

[0086] (8) After cooling, add 1 mL of saturated NaCl solution and 1 mL of n-hexane, shake and let stand for a while. Pipette the supernatant, filter it with an organic phase filter membrane, and transfer it to a gas chromatography vial for testing.

[0087] The GC-MS mass spectrometry detection method of succinic acid is as follows:

[0088] Instrument model: Agilent 7890B GC; chromatographic column: Agilent DB-WAX UI (0.25mm×0.25um×30m); injection volume: 1uL; injection port temperature: 250℃; carrier gas: high-purity nitrogen; heating program: 100℃ for 2min; increase to 240℃ at 15℃ / min and hold for 5min; FID detector: 250℃, air 400mL / min, hydrogen 30mL / min, tail gas 25mL / min.

[0089] The GC-MS mass spectrometry detection method of succinic acid is as follows:

[0090] Instrument model: Agilent 7890A GC / 7200Q-TOF M gas chromatography-mass spectrometer; chromatographic column: Agilent J&WHP-5MS (0.25 mm×0.25 um×30 m); injection volume: 1 uL; injection port temperature: 250°C; heating program: 100°C for 2 min; increase to 240°C at 15°C / min and hold for 5 min; ion source temperature: 230°C, filament current: 35 uA, electron energy: 70 eV, quadrupole 240°C, full scan range: 50-500 amus.

[0091] The GC test results showed that the recombinant Yarrowia spp. strain YL-3 could generate new products ( Figure 4, peak 2), the elution time is 15.098min, which is consistent with the elution time of the standard product of methyl succinate. The gas chromatography-mass spectrometry results show that ( Figure 5 ) The molecular weight of the new product is 320, which is consistent with the molecular weight of the standard product of methyl succinate, and the ion fragments are basically the same.

[0092] The above describes the basic principle, main features and advantages of the present invention. Those skilled in the art should understand that the present invention is not limited to the above embodiments. The above embodiments and descriptions are only for explaining the principles of the present invention. The present invention may be subject to various changes and improvements without departing from the spirit and scope of the present invention. These changes and improvements fall within the scope of the present invention to be protected. The scope of protection of the present invention is defined by the attached claims and their equivalents.

[0093] Sequence information:

[0094] Seq.ID No: 1

[0095] Sequence length: 1410

[0096] Sequence type: DNA

[0097] Species: Torreya grandis

[0098] Sequence name: TgDES

[0099]

[0100]

[0101] Seq.ID No: 2

[0102] Sequence length: 469

[0103] Sequence Type: PRT

[0104] Species: Torreya grandis Name: delta 5desaturase

[0105]

[0106]

[0107] Seq.ID No: 3

[0108] Sequence length: 828 Sequence type: DNA

[0109] Species: Artificial

[0110] Species: Mortierella alpina Name: ME3S

[0111]

[0112]

[0113] Seq.ID No: 4 Sequence length: 777 Sequence type: DNA

[0114] Species: Artificial Species: Euglena gracilis Name: EgD9eS

[0115]

[0116] Seq.ID No: 5

[0117] Sequence length: 1434

[0118] Sequence type: DNA

[0119] Species: Artificial

[0120] Species: Fusarium monoliforme Name: FmD12S

[0121]

[0122] Seq.ID No:6

[0123] Sequence length: 1410

[0124] Sequence type: DNA

[0125] Species: Artificial

[0126] Species: Torreya grandis

[0127] Name: Codon optimization of TgDES

[0128]

Claims

1. A Δ5 desaturase from Torreya grandis, characterized in that The amino acid sequence of the enzyme is shown in SEQ ID NO:

2.

2. The gene encoding the Δ5 desaturase according to claim 1 (TgDES), characterized in that The nucleotide sequence is shown in SEQ ID NO: 1, or the sequence after codon optimization is shown in SEQ ID NO:

6.

3. A genetically engineered bacterium producing pyralidin, characterized in that: The phosphodiesterase-producing genetically engineered bacteria contain and can express genes ME3S, EgD9eS, FmD12S and TgDES, and the nucleotide sequences of the genes ME3S, EgD9eS, FmD12S and TgDES are shown in SEQ ID No: 3, SEQ ID No: 4, SEQ ID No: 5 and SEQ ID No: 6, respectively.

4. The succinic acid-producing genetically engineered bacteria according to claim 3, wherein the chassis cells are Yarrowia lipolytica.

5. The succinic acid-producing genetically engineered bacteria according to claim 3, wherein the genes ME3S, EgD9eS, FmD12S and TgDES are expressed under the control of a strong endogenous promoter and terminator of Yarrowia lipolytica; preferred promoters include pYAT1, pTEFIN, pGPD, pFBA1 and pEXP; preferred terminators include tLIP2 and tPEX20.

6. The succinic acid-producing genetically engineered bacteria according to claim 3, wherein the EgD9eS gene is introduced in multiple copies.

7. The succinic acid-producing genetically engineered bacteria according to claim 3, wherein the genetically engineered bacteria comprises a ME3S-EgD9eS gene fragment; preferably, the fragment is inserted into the KU80 site.

8. The succinic acid-producing genetically engineered bacteria according to claim 3, wherein the genetically engineered bacteria comprises a FmD12S-EgD9eS gene fragment, and preferably, the fragment is inserted into the IntC-2 site.

9. The succinic acid-producing genetically engineered bacteria according to claim 3, wherein the TgDES gene fragment is inserted into the IntC-3 site.

10. The method for constructing a succinic acid-producing genetically engineered bacterium according to claim 3, characterized in that: The following steps are involved: An expression cassette containing the gene C16 / 18 fatty acid elongase (ME3S) from Mortierella alpina, the gene Δ9 elongase (EgD9eS) from Euglenagracilis, and the functional elements of the endogenous strong promoter and terminator of Yarrowia lipolytica was constructed; the expression cassette was integrated into the KU80 site on the Yarrowia lipolytica genome to obtain the recombinant Yarrowia lipolytica strain YL-1; An expression cassette containing the gene Δ12 desaturase (FmD12S) from Fusarium monoliforme, the gene Δ9 elongase (EgD9eS) from Euglenagracilis, and the functional elements of the endogenous strong promoter and terminator of Yarrowia lipolytica was constructed; the expression cassette was integrated into the IntC-2 site on the genome of strain YL-1 to obtain the recombinant Yarrowia lipolytica strain YL-2; An expression cassette containing the Δ5 desaturase gene (TgDES) from Torreyagrandis and the functional elements of the strong endogenous promoter and terminator of Yarrowia lipolytica was constructed; the expression cassette was integrated into the IntC-3 site on the genome of strain YL-2 to obtain the recombinant Yarrowia lipolytica strain YL-3, i.e., the succinic acid-producing genetically engineered strain.

11. A method for synthesizing sauroponic acid, characterized in that: The sauroponic acid is synthesized by fermentation using the sauroponic acid-producing genetically engineered bacteria described in claim 3 or the Yarrowia lipolytica strain YL-3 constructed by the method described in claim 10.

Citation Information

Cited By

  • Mesophilic carotenoid-producing recombinant yarrowia lipolytica strain as well as construction method and application thereof

    CN120310669A

  • Recombinant carotenoid-producing yarrowia lipolytica strain, method for constructing same, and use thereof

    CN120310669B